A real-world pharmacovigilance study of FDA adverse event reporting system events for Capmatinib ..read more

CDK9 inhibition as an effective therapy for small cell lung cancer ..read more

Prediction of TKI response in EGFR-mutant lung cancer patients-derived organoids using malignant pleural effusion ..read more

Structure-specific rigid dose accumulation dosimetric analysis of ablative stereotactic MRI-guided adaptive radiation therapy in ultracentral lung lesions Bryant et al. report findings of a dosimetric analysis of adapted versus non-adapted radiation therapy plans of ultracentral lung lesions treated with ablative stereotactic MRI-guided adaptive radiation therapy. The differences demonstrated help to elucidate the therapeutic window improvements of daily plan adaptation ..read more

Single-cell and spatial transcriptomics analysis of non-small cell lung cancer Myeloid cell populations play a critical role in lung cancer progression. Here, the authors use scRNA-seq and spatial transcriptomics to identify changes in the phenotype of macrophages within the tumour microenvironment ..read more

Clinical significance of the advanced lung cancer inflammation index in patients with limited-stage small cell lung cancer treated with chemoradiotherapy ..read more

HMGN1 loss sensitizes lung cancer cells to chemotherapy ..read more

Precise and automated lung cancer cell classification using deep neural network with multiscale features and model distillation ..read more

Comparison of preventive effects of combined furosemide and mannitol versus single diuretics, furosemide or mannitol, on cisplatin-induced nephrotoxicity ..read more

Epithelial−mesenchymal transition induced by tumor cell-intrinsic PD-L1 signaling predicts a poor response to immune checkpoint inhibitors in PD-L1-high lung cancer ..read more